RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Phrontline Biopharma

Phrontline Biopharma

Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.

Latest funding

$40M Series A ·

Led by Decheng Capital · Source: ifastdata.com

Total raised: $100M across 2 sourced rounds

All 2 rounds ↓
LinkedIn: linkedin.com.
Sectors: Biopharma, Manufacturing, Medical, Oncology.
Stage: Series A.
Based in: Shanghai, China.
Total raised: $100M in 2 sourced rounds.
Last round: Nov 12, 2026 · 1 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Nov 13, 2026.

Funding rounds

  1. Series A · $40M
  2. Seed · $60M

Investors

Companies like Phrontline Biopharma

Other companies backed by Decheng Capital

Decheng Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/phrontline-biopharma (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy